ace527
Vaccineexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2009 (NCT00901654)
Timeline
Indications
Mechanism of action
- Escherichia coli O157:H7Immunity, active
Escherichia coli O157:H7 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ace527
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01739231 | Phase 1/Phase 2 (Phase 2) | Sep 1, 2012 | Johns Hopkins University, PATH |
| NCT01060748 | Phase 2 | Mar 1, 2010 | Johns Hopkins University, Pierrel Research, TD Vaccines A/S |
| NCT00901654 | Phase 1 | Jun 1, 2009 | Johns Hopkins University, Pierrel Research, TD Vaccines A/S |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Johns Hopkins University | Academic/Hospital | 3 | 0 | 2 | 2009 |
| Pierrel Research | For profit | 2 | 0 | 2 | 2009 |
| TD Vaccines A/S | For profit | 2 | 2 | 2 | 2009 |
| PATH | Academic/Hospital | 1 | 1 | 1 | 2012 |
4 organizations
Page 1 / 1